Cencora Inc., US03073E1055

Cencora stock faces FTC challenge to 3.5 billion dollar MWI sale

Published on 11/16/2026 at 12:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cencora stock faces a US antitrust lawsuit targeting its planned sale of MWI Animal Health to Covetrus. The transaction now moves into court proceedings.

FTC challenges proposed MWI sale

  • The Federal Trade Commission filed an antitrust lawsuit over Cencora's planned divestment of MWI Animal Health to Covetrus.
  • The agency argues that the transaction would eliminate direct competition between two major U.S. veterinary distributors.
  • J.P. Morgan analysts expect the challenge to leave Cencora's forecast intact.
Cencora Inc., US03073E1055, Illustration mit AI erstellt.

On Friday, November 13, the U.S. Federal Trade Commission filed a lawsuit against Cencora's planned sale of MWI Animal Health to Covetrus, according to Reuters. The agency is seeking to block the 3.5 billion dollar transaction in the U.S. District Court for the Southern District of New York.

FTC action challenges proposed MWI sale

The FTC said the proposed deal would combine the two largest U.S. distributors of veterinary medicines and clinic supplies. In the regulator's view, the transaction would remove head-to-head competition and could raise costs for veterinary clinics and pet owners.

Cencora agreed in February to sell MWI to privately held Covetrus. The FTC lawsuit is joined by attorneys general from 13 states. The regulator said MWI and Covetrus compete through discounts and rebates with independent veterinarians and larger clinic chains.

Deal outcome moves to court

The lawsuit creates a new legal hurdle for Cencora's planned divestment. Reuters reported that Cencora and Covetrus had not immediately responded to requests for comment. The court proceedings will determine whether the proposed sale can proceed in its current form.

J.P. Morgan analysts told Reuters that they do not expect the FTC challenge to affect Cencora's forecast. The brokerage expects Cencora to continue pursuing the transaction on strategic grounds and could consider alternative MWI transactions if the sale is ultimately blocked.

Current trading context

Cencora stock traded at 328.65 euros on Lang & Schwarz at 12:39 CET on Monday, November 16.

Cencora company details

  • Company: Cencora Inc.
  • ISIN: US03073E1055
  • Ticker: COR
  • Lang & Schwarz quote: 328.65 euros on November 16, 2026, at 12:39 CET

The broader U.S. equity market can be followed through the S&P 500.

For further company developments, see More news and analyses on Cencora stock.

Disclaimer...
en | US03073E1055 | CENCORA INC. | boerse | 70520561 | bgmi